Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation.

Ann Rheum Dis · 2014 · PMC3888596 · PMID 23300117

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

22 A systematic review by Pollono et al 22 found a slight trend of increases in TC and HDL after anti-TNF therapy.

also in 3,746 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.